IMDX
Insight Molecular Diagnostics
IMDX
IMDX
41 hedge funds and large institutions have $20.3M invested in Insight Molecular Diagnostics in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less capital invested
Capital invested by funds: $22.5M → $20.3M (-$2.18M)
Holders
41
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$604K | |
| 2 | +$211K | |
| 3 | +$82K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$56.7K |
| 5 |
Citigroup
New York
|
+$51K |
Top Sellers
| 1 | -$500K | |
| 2 | -$157K | |
| 3 | -$74K | |
| 4 |
Barclays
London,
United Kingdom
|
-$6K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$545 |